๐ข ๐๐๐๐ ๐๐: $Clearmind Medicine(CMND.US) Clearmind Medicine Secures U.S. Patent for MEAI Binge Behavior Treatment
๐ ๐๐๐ฒ ๐๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ:โค ๐๐ฅ๐๐๐ซ๐ฆ๐ข๐ง๐ ๐๐๐๐ข๐๐ข๐ง๐ received ๐.๐. Patent No. ๐๐,๐๐๐,๐๐๐.โค Patent covers ๐๐๐๐ and related 2-aminoindane derivatives for binge behavior regulation.โค Technology targets ๐๐ฑ๐๐๐ฌ๐ฌ๐ข๐ฏ๐ ๐๐ซ๐ข๐ง๐ค๐ข๐ง๐ , overeating, and other compulsive disorders.โค New patent expands protection beyond previously granted ๐.๐. Patent No. ๐๐,๐๐๐,๐๐๐.โค Clearmind's IP portfolio now includes ๐๐ patent families and ๐๐ granted patents.๐ ๐๐ก๐ฒ ๐๐ญ ๐๐๐ญ๐ญ๐๐ซ๐ฌ:โค Strengthens Clearmind's ๐ข๐ง๐ญ๐๐ฅ๐ฅ๐๐๐ญ๐ฎ๐๐ฅ ๐ฉ๐ซ๐จ๐ฉ๐๐ซ๐ญ๐ฒ protection for MEAI.โค Expands exclusivity for therapies targeting ๐๐๐๐ข๐๐ญ๐ข๐จ๐ง and compulsive behaviors.โค Broader patent coverage may enhance future ๐ฅ๐ข๐๐๐ง๐ฌ๐ข๐ง๐ and commercialization opportunities.